World Stem Cell Report

Printer-friendly version
World Stem Cell Report 2013
Report: 20132012 | 2011 | 2010 | 2009

All World Stem Cell Summit attendees receive a free copy of the World Stem Cell Report.

The Genetics Policy Institute (GPI) and Mary Ann Liebert, Inc., publishers have announced that the 2013 World Stem Cell Report will be published as a special supplement to the peer-reviewed journal Stem Cells and Development. Dr. Graham Parker and Bernard Siegel will serve as Co-Editors-in-Chief, joined by Rosario Isasi (McGill University) as Managing Editor

The Report will be made available to all subscribers of Stem Cells and Development and complimentary to attendees of the World Stem Cell Summit. The Summit program delivers on the "big picture" featuring 170+ prominent scientists, business leaders, regulators, policy-makers, advocates, economic development officers, experts in law and ethics, and visionary gurus who will discuss the latest scientific discoveries, business models, legal and regulatory solutions, and best practices. The Summit is expected to attract attendees from more than 40 nations.

2013 World Stem Cell Report Table of Contents

Introduction

  • An interview with Mary Ann Liebert, Publisher, Stem Cells and Development
  • National Institutes of Health Center for Regenerative Medicine: Putting Science into Practice
    Mahendra Rao, MD, PhD, NIH Center for Regenerative Medicine
  • An interview with Teruo Okano, PhD, President, The Japanese Society for Regenerative Medicine
  • Key action items for the stem cell field looking to 2014
    Paul Knoepfler, PhD, University of California, Davis School of Medicine

Regional Initiatives

  • Regulation of cell-based therapies in Europe: Current Challenges and Emerging Issues
    Alessandro Blasimme, MA, PhD
    Université Paul Sabatier de Toulouse, France
  • Regenerative Medicine Blueprint
    Andre Terzic, MD, PhD, C. Michel Harper Jr., MD, Gregory J. Gores, MD, and Michael A. Pfenning
    Center for Regenerative Medicine, Mayo Clinic
  • Somatic cell nuclear transfer in Oregon: Expanding the Pluripotent Space & Informing Research Ethics
    Geoffrey P Lomax, DrPH
    California Institute of Regenerative Medicine
  • Fostering Public Cord Blood Banking and Research in Canada
    Rosario Isasi, JD, MPH
    Centre of Genomics and Policy
    McGill University and Génome Québec Innovation Centre
  • Growing a UK Cell Therapy Industry Generating Health and Wealth
    Keith Thompson, Emma Palmer Foster
    The Cell Therapy Catapult
  • Stem Cell Research and Therapies in Argentina: Legal and regulatory approach
    Fabiana C. de Arzuaga
    Ministry of Science, Technology and Productive Innovation, Advisory Commission on Cellular Therapies and Regenerative Medicine; University of Buenos Aires, Argentina

Legal Initiatives

  • FDA Should Solidify the Legal Basis for Its Authority Over Reproductive Cloning
    Bernard Siegel, JD
    Genetics Policy Institute (GPI)
  • Arnold I. Friede, JD
    Sandler, Travis & Rosenberg, P.A.
  • The Ethical and Regulatory Compliant Training and Practice of Regenerative Surgery in the United States and Abroad.
    Allen Wu, MD, FACOG, FAACS
    The Morrow Institute, Regenerative Surgery
    Nicholas A Zachariades, JD, PhD
    Duane Morris LLP
    Stem Cells: Intellectual Property Issues in Regenerative Medicine
  • The Implementation of Novel Collaborative Structures for the Identification and Resolution of Barriers to Stem Cell Translation
    David A Brindley, Anna French, Jane Suh, et al.
    The Oxford – UCL Centre for the Advancement of Sustainable Medical Innovation (CASMI)
  • Navigating the U.S. FDA's Regulatory Science Initiative: An Imperative for Stem Cell Research and Regenerative Medicine Advocates
    Alan Jakimo, JD, MBA
    Sidley Austin LLP
  • Patenting human embryonic stem cell-derived inventions?
    Martin Heyer
    Institute of Science and Ethics - Stem Cell Network North Rhine-Westphalia

Business Initiatives

  • Commercialization and Stem Cell Research: A Review of Emerging Issues
    Sarah Burningham, LL.B., BCL, Timothy Caulfield, LL.B., LL.M.
    University of Alberta, Canada
  • Canadian Centre for Commercialization of Regenerative Medicine: Moving Regenerative Medicine commercialization in Canada forward
    Stacey Johnson
    Centre for Commercialization of Regenerative Medicine
  • Value-Engineered Translation for Regenerative Medicine: Meeting the Needs of Health Systems
    Tania Bubela, PhD, JD, Christopher McCabe, PhD
    University of Alberta
  • Background and Future Considerations for Human Cord Blood Hematopoietic Cell Transplantation, Including Economic Concerns
    Hal E. Broxmeyer, PhD
    Indiana University School of Medicine
  • The Next Frontier: Stem Cells and The Center for the Advancement of Science in Space
    Patrick O'Neill
    The Center for the Advancement of Science in Space
  • Translation of Amnion Stem Cells to the Clinic
    Stephen Strom, PhD
    Karolinska Institutet - Laboratory Medicine